Texas Instruments director Robert E. Sanchez reported new equity awards. On January 29, 2026, he acquired 525 shares of common stock at a price of $0, increasing his directly held common shares to 21,600.
He was also granted a non-qualified stock option for 1,860 shares of common stock with an exercise price of $218.97. The option becomes exercisable in four equal installments beginning on January 29, 2027. Both awards were granted under the Texas Instruments 2018 Director Compensation Plan.
Texas Instruments Sr. Vice President Ron Amichai reported new equity awards and a related share transaction. On January 29, 2026, he acquired 13,473 shares of common stock at $0 per share as part of an award of restricted stock units under the 2024 Long-Term Incentive Plan, bringing his direct common stock holdings to 87,840 shares at that time.
On the same date, he received a non-qualified stock option for 47,723 shares with an exercise price of $218.97 per share; the option becomes exercisable in four equal installments beginning on January 29, 2027, and he directly holds the full 47,723 options. On January 30, 2026, a transaction coded F disposed of 4,286 common shares at $218.97 per share, leaving him with 83,554 directly held common shares.
Texas Instruments director Martin S. Craighead reported equity awards from the company. On January 29, 2026, he received 525 shares of common stock at $0 under the Texas Instruments 2018 Director Compensation Plan, bringing his directly held common stock to 24,359 shares.
On the same date, he was also granted a non-qualified stock option for 1,860 shares with an exercise price of $218.97 per share. This option becomes exercisable in four equal installments beginning January 29, 2027 and runs until January 29, 2036.
Texas Instruments director Todd M. Bluedorn reported new equity awards in the company. On January 29, 2026, he received 525 shares of common stock at $0 per share, noted as an award of restricted stock units under the Texas Instruments 2018 Director Compensation Plan.
He was also granted a nonqualified stock option for 1,860 shares with an exercise price of $218.97 per share. This option becomes exercisable in four equal installments beginning on January 29, 2027, and expires on January 29, 2036. Following these transactions, he beneficially owned 8,191 shares of common stock and 1,860 stock options, all held directly.
Texas Instruments executive Katharine Kane reported new equity awards and a small share withholding transaction. On January 29, 2026, she received 4,796 shares of common stock as a restricted stock unit award under the 2024 Long-Term Incentive Plan and 16,987 nonqualified stock options with an exercise price of $218.97 per share, vesting in four equal installments beginning January 29, 2027 and expiring January 29, 2036. On January 30, 2026, 311 shares of common stock were withheld at $218.97 per share, typically for tax obligations, leaving her with 25,181 shares of common stock and 16,987 stock options held directly.
Texas Instruments director Ronald Kirk reported equity awards from the company. On January 29, 2026, he acquired 525 shares of common stock at a price of $0, representing restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. After this award, he directly owned 15,462 common shares.
He was also granted a nonqualified stock option for 1,860 shares of Texas Instruments common stock at an exercise price of $218.97 per share. The option expires on January 29, 2036 and becomes exercisable in four equal installments beginning on January 29, 2027.
Texas Instruments Inc. director Mark A. Blinn reported new equity awards. On January 29, 2026, he acquired 525 shares of common stock at $0, reflecting restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. Following this, he directly held 12,242 common shares. He also received a nonqualified stock option for 1,860 shares at an exercise price of $218.97 per share, expiring January 29, 2036, which becomes exercisable in four equal installments beginning on January 29, 2027. Additional indirect holdings include 3,046 and 6,000 shares in trusts for family members where beneficial ownership is disclaimed, and 6,000 shares in a trust benefiting him as sole trustee.
Texas Instruments Inc. Chairman, President & CEO Ilan Haviv reported new equity awards and a related share withholding. On January 29, 2026, he acquired 47,952 shares of common stock at $0, described as restricted stock units granted under the 2024 Long-Term Incentive Plan, bringing his directly held common stock to 214,168 shares.
On the same date, he was granted a non-qualified stock option for 169,862 shares of common stock at an exercise price of $218.97 per share, which becomes exercisable in four equal installments beginning on January 29, 2027. On January 30, 2026, 9,860 shares of common stock were disposed of at $218.97 under code "F" (typically a tax withholding), leaving 204,308 shares of common stock held directly. He also reports 32,990 shares held indirectly by his spouse.
Texas Instruments director Pamela H. Patsley reported equity awards from the company. On January 29, 2026, she acquired 525 shares of common stock at a price of $0, described as an award of restricted stock units under the Texas Instruments 2018 Director Compensation Plan. Following this grant, she directly owned 34,487 shares of common stock.
She was also granted a non-qualified stock option covering 1,860 shares of common stock at an exercise price of $218.97 per share. This option becomes exercisable in four equal installments beginning on January 29, 2027, and expires on January 29, 2036. After this transaction, she held 1,860 stock options directly.
Texas Instruments Inc. reported new equity awards to Senior Vice President Christine Witzsche. On January 29, 2026, she received 4,796 shares of common stock at a price of $0, described as restricted stock units under the 2024 Long-Term Incentive Plan.
She was also granted a non-qualified stock option covering 16,987 shares of common stock at an exercise price of $218.97 per share, expiring on January 29, 2036. The option becomes exercisable in four equal installments beginning on January 29, 2027. After the stock grant, she beneficially owned 25,617 common shares directly.